451 related articles for article (PubMed ID: 24062306)
1. The N-terminal flanking region of the A1 domain regulates the force-dependent binding of von Willebrand factor to platelet glycoprotein Ibα.
Ju L; Dong JF; Cruz MA; Zhu C
J Biol Chem; 2013 Nov; 288(45):32289-32301. PubMed ID: 24062306
[TBL] [Abstract][Full Text] [Related]
2. Platelet glycoprotein Ibalpha forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF.
Yago T; Lou J; Wu T; Yang J; Miner JJ; Coburn L; López JA; Cruz MA; Dong JF; McIntire LV; McEver RP; Zhu C
J Clin Invest; 2008 Sep; 118(9):3195-207. PubMed ID: 18725999
[TBL] [Abstract][Full Text] [Related]
3. Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.
Auton M; Sedlák E; Marek J; Wu T; Zhu C; Cruz MA
Biophys J; 2009 Jul; 97(2):618-27. PubMed ID: 19619477
[TBL] [Abstract][Full Text] [Related]
4. GPIbα-vWF rolling under shear stress shows differences between type 2B and 2M von Willebrand disease.
Coburn LA; Damaraju VS; Dozic S; Eskin SG; Cruz MA; McIntire LV
Biophys J; 2011 Jan; 100(2):304-12. PubMed ID: 21244826
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the intrinsic properties of the GPIbalpha-VWF tether bond define the kinetics of the platelet-type von Willebrand disease mutation, Gly233Val.
Doggett TA; Girdhar G; Lawshe A; Miller JL; Laurenzi IJ; Diamond SL; Diacovo TG
Blood; 2003 Jul; 102(1):152-60. PubMed ID: 12637314
[TBL] [Abstract][Full Text] [Related]
6. Purified A2 domain of von Willebrand factor binds to the active conformation of von Willebrand factor and blocks the interaction with platelet glycoprotein Ibalpha.
Martin C; Morales LD; Cruz MA
J Thromb Haemost; 2007 Jul; 5(7):1363-70. PubMed ID: 17389010
[TBL] [Abstract][Full Text] [Related]
7. A discontinuous autoinhibitory module masks the A1 domain of von Willebrand factor.
Deng W; Wang Y; Druzak SA; Healey JF; Syed AK; Lollar P; Li R
J Thromb Haemost; 2017 Sep; 15(9):1867-1877. PubMed ID: 28692141
[TBL] [Abstract][Full Text] [Related]
8. N-terminal flanking region of A1 domain in von Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress.
Auton M; Sowa KE; Behymer M; Cruz MA
J Biol Chem; 2012 Apr; 287(18):14579-85. PubMed ID: 22431729
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor-A1 domain binds platelet glycoprotein Ibα in multiple states with distinctive force-dependent dissociation kinetics.
Ju L; Chen Y; Zhou F; Lu H; Cruz MA; Zhu C
Thromb Res; 2015 Sep; 136(3):606-12. PubMed ID: 26213126
[TBL] [Abstract][Full Text] [Related]
10. The linker between the D3 and A1 domains of vWF suppresses A1-GPIbα catch bonds by site-specific binding to the A1 domain.
Tischer A; Cruz MA; Auton M
Protein Sci; 2013 Aug; 22(8):1049-59. PubMed ID: 23775931
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations.
Dumas JJ; Kumar R; McDonagh T; Sullivan F; Stahl ML; Somers WS; Mosyak L
J Biol Chem; 2004 May; 279(22):23327-34. PubMed ID: 15039442
[TBL] [Abstract][Full Text] [Related]
12. Platelet adhesion: a game of catch and release.
Andrews RK; Berndt MC
J Clin Invest; 2008 Sep; 118(9):3009-11. PubMed ID: 18725992
[TBL] [Abstract][Full Text] [Related]
13. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.
Miura S; Li CQ; Cao Z; Wang H; Wardell MR; Sadler JE
J Biol Chem; 2000 Mar; 275(11):7539-46. PubMed ID: 10713059
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
[TBL] [Abstract][Full Text] [Related]
16. The soluble N-terminal autoinhibitory module of the A1 domain in von Willebrand factor partially suppresses its catch bond with glycoprotein Ibα in a sandwich complex.
Zhao YC; Li Z; Ju LA
Phys Chem Chem Phys; 2022 Jun; 24(24):14857-14865. PubMed ID: 35698887
[TBL] [Abstract][Full Text] [Related]
17. Platelet GpIba binding to von Willebrand Factor under fluid shear:contributions of the D′D3-domain, A1-domain flanking peptide and O-linked glycans.
Madabhushi SR; Zhang C; Kelkar A; Dayananda KM; Neelamegham S
J Am Heart Assoc; 2014 Oct; 3(5):e001420. PubMed ID: 25341886
[TBL] [Abstract][Full Text] [Related]
18. Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha.
Bonnefoy A; Yamamoto H; Thys C; Kito M; Vermylen J; Hoylaerts MF
Blood; 2003 Feb; 101(4):1375-83. PubMed ID: 12393553
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of VWF-mediated platelet GPIbalpha binding.
Auton M; Zhu C; Cruz MA
Biophys J; 2010 Aug; 99(4):1192-201. PubMed ID: 20713003
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha.
Cauwenberghs N; Vanhoorelbeke K; Vauterin S; Westra DF; Romo G; Huizinga EG; Lopez JA; Berndt MC; Harsfalvi J; Deckmyn H
Blood; 2001 Aug; 98(3):652-60. PubMed ID: 11468163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
